BIOPHARMA
By
Unlearn AI’s Breakthroughs in AI-Driven Clinical Development: 2024 Milestones and Future Outlook
San Francisco – December 12, 2024 Unlearn AI has emerged as a leader in AI-powered clinical trial innovation,…
How Unlearn AI Is Increasing the Efficiency of Phase 2 Clinical Trials with AI-Powered TwinRCT
December 11, 2024 Enhanced TwinRCT™ 3.0 Unlearn® has introduced an upgraded version of its AI-driven TwinRCT™ solution—TwinRCT 3.0,…
Relation Therapeutics, NVIDIA-Backed AI-Biotech, and GSK Announce Strategic Collaborations to Advance Therapies for Fibrotic Diseases and Osteoarthritis
London, UK – December 10, 2024 Relation, a leader in computational and experimental drug discovery, has announced two…
Recursion Reports Promising Interim Data for AI-Designed CDK7 Inhibitor in Ovarian Cancer
Salt Lake City – December 9, 2024 Recursion (Nasdaq: RXRX), a leader in AI-powered drug discovery, has released…
Recursion Doses First Patient in Phase 1/2 Trial of REC-1245 for Biomarker-Enriched Solid Tumors and Lymphoma
Recursion (NASDAQ: RXRX), a cutting-edge clinical-stage TechBio company, has announced the successful dosing of the first patient in…
AI Drug Discovery Leaders Recursion and Exscientia Merge to Transform Drug Discovery
Recursion and Exscientia, two trailblazers in AI-driven drug discovery, have officially merged to form a technology-powered platform aimed…
NVIDIA Expands AI-Driven Drug Discovery with BioNeMo Framework
November 18, 2024 NVIDIA has launched a major initiative to scale AI-powered drug discovery through the open-source BioNeMo…
ImmunAI and Teva Partner to Enhance Clinical Trials with AI-Driven Precision in Oncology and Immunology
New York, NY – Nov 14, 2024 Strategic Collaboration Aims to Improve Drug Development Efficiency and Patient Outcomes:ImmunAI,…
Medable and Google Cloud Partner to Advance AI-Powered Digital Clinical Trials
PALO ALTO, Calif. – October 30, 2024 Strategic Collaboration to Accelerate Clinical Research Medable Inc., a leader in…
Odyssey and Terray Forge AI-Powered Partnership to Advance Transcription Factor Therapies
Boston and Los Angeles – Oct 28, 2024 With Odyssey’s established track record in immunology and Terray’s cutting-edge…
Dyno Therapeutics and Roche Expand Strategic Partnership for AI-Driven AAV Gene Therapies in Neurological Diseases
October 24, 2024 Dyno Therapeutics has expanded its collaboration with Roche to advance next-generation adeno-associated virus (AAV) vectors…
Six Ways Johnson & Johnson is Leveraging AI to Transform Healthcare
October 10, 2024 Johnson & Johnson is at the forefront of integrating Artificial Intelligence (AI) to drive healthcare…
BullFrog AI Publishes Data Highlighting Potential of BF-114 in Liver Disease Treatment
Gaithersburg, Md – Oct 9 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
ProJenX and Unlearn AI Collaborate to Advance AI-Powered Clinical Trials for ALS
San Francisco – September 27, 2024 ProJenX, a clinical-stage biotech company, has partnered with Unlearn AI to enhance…
Novartis and Generate:Biomedicines Announce Strategic AI-Driven Protein Therapeutics Partnership Worth Up to $1 Billion
Somerville, MA — Sept 24, 2024 Combining AI innovation with pharma expertise to accelerate drug development and tackle…
Eli Lilly and Genetic Leap Forge $409M Strategic Collaboration to Advance AI-Powered RNA Drug Discovery
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into a landmark $409…
Rakovina Therapeutics and Variational AI Partner to Advance AI-Driven Cancer Drug Discovery
Vancouver, BC – September 17, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV), a Canadian biopharmaceutical company focused on developing…
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic Collaboration with Genesis Therapeutics
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have entered into a…
